![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Monday, February 09, 2009 10:20:21 AM
I think the Doc's did us a huge favor with this move. If you think about how negotiations go, I am sure that Big Pharma would put have put up the $1.8m (round number) for the lab facilities, etc, but they wanted control of the "stuff". The Docs found a way to meet a need (buy needed stuff) without having "sell" the control for the same $1.8m. They were very resourceful and found a way to protect themselves, their property, and us too.
I think this outcome explains what has been happening. Big Pharma knew that there was a significant need for more "stuff" in order to do the tests. They believed they could play "chicken" with the Docs, to get them to sign an agreement for a couple of $m or so, but the Docs didn't want to give up the control. Big Pharma had the $$$s, the Docs the intellectual property, so for the last two months they have been going back and forth and Big Pharma believed that the Doc's need for the money was greater than their desire to hold on to control.
Now this announcement might also be a negotiating ploy as well, so this matter may not be over.
Most of the time when insiders sell it is a bad sign, but in this case, I choose to believe it is a good sign. They are willing to reinvest directly into the business. They are not taking profit.
Recent NNVC News
- NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • InvestorsHub NewsWire • 05/02/2024 02:07:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 09:53:32 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/14/2024 09:55:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/19/2024 09:44:48 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 12/04/2023 09:08:49 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 10/13/2023 08:30:41 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 09/28/2023 08:44:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/01/2023 08:46:45 PM
Peer To Peer Network aka Mobicard™ Launches AI Investor Chatbot Boosting Engagement & Lead Generation on Ihub • PTOP • Jul 15, 2024 8:30 AM
Greenlite Ventures Announces AI Integration into No Limit Platforms • GRNL • Jul 15, 2024 8:00 AM
Cannabix Technologies and Omega Laboratories Inc. Provide Positive Developments on Marijuana Breathalyzer Testing • BLO • Jul 11, 2024 8:21 AM
ECGI Holdings Enhances Board with Artificial Intelligence (AI) Expert Ahead of Allon Apparel Launch • ECGI • Jul 10, 2024 8:30 AM
Avant Technologies to Meet Unmet Needs in AI Industry While Addressing Sustainability Concerns • AVAI • Jul 10, 2024 8:00 AM
Panther Minerals Inc. Launches Investor Connect AI Chatbot for Enhanced Investor Engagement and Lead Generation • PURR • Jul 9, 2024 9:00 AM